IP Verse

Immunohistochemical Assay For Detecting Expression Of Programmed Death Ligand 1 (Pd-L1) In Tumor Tissue - EP2981821

The patent EP2981821 was granted to Merck Sharp & Dohme on Nov 3, 2021. The application was originally filed on Mar 31, 2014 under application number EP14778739A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2981821

MERCK SHARP & DOHME
Application Number
EP14778739A
Filing Date
Mar 31, 2014
Status
Patent Maintained As Amended
Oct 1, 2021
Grant Date
Nov 3, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

FORSYTHESep 19, 2019J A KEMPADMISSIBLE

Patent Citations (25) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP19890303964
DESCRIPTIONEP0216846
DESCRIPTIONEP0256055
DESCRIPTIONEP0323997
DESCRIPTIONUS4275149
DESCRIPTIONUS4318980
DESCRIPTIONUS4399216
DESCRIPTIONUS4737456
DESCRIPTIONUS4740461
DESCRIPTIONUS4816567
DESCRIPTIONUS4912040
DESCRIPTIONUS4959455
DESCRIPTIONUS6331415
DESCRIPTIONUS7521051
DESCRIPTIONUS8008449
DESCRIPTIONUS8354509
DESCRIPTIONUS8383796
INTERNATIONAL-SEARCH-REPORTUS2010266617
INTERNATIONAL-SEARCH-REPORTUS2012251537
INTERNATIONAL-SEARCH-REPORTUS2013064882
INTERNATIONAL-SEARCH-REPORTWO2010132958
OPPOSITIONWO2007082154
OPPOSITIONWO2008156712
OPPOSITIONWO2013173223
SEARCHWO2008156712

Non-Patent Literature (NPL) Citations (77) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- AL-LAZIKANI et al., JMB, (19970000), vol. 273, pages 927 - 948
DESCRIPTION- ALLRED DC; HARVEY JM; BERARDO M; CLARK GM., Mod Pathol., (19980000), vol. 11, pages 155 - 168
DESCRIPTION- ALTSCHUL, S.F. et al., J. Mol. Biol., (19900000), vol. 215, pages 403 - 410
DESCRIPTION- ALTSCHUL, S.F. et al., J. Mol. Evol., (19930000), vol. 36, pages 290 - 300
DESCRIPTION- ALTSCHUL, S.F. et al., Nucleic Acids Res., (19970000), vol. 25, pages 3389 - 3402
DESCRIPTION- ALTSCHUL, S.F., J. Mol. Biol., (19910000), vol. 219, pages 555 - 565
DESCRIPTION- "A model of evolutionary change in proteins", DAYHOFF, M.O. et al., Atlas of Protein Sequence and Structure, (19780000), vol. 5, pages 345 - 352
DESCRIPTION- BRAHMER J.R. et al., J Clin Oncol., (20100000), vol. 28, pages 3167 - 3175
DESCRIPTION- CHOTHIA et al., J Mol. Biol., (19870000), vol. 196, pages 901 - 917
DESCRIPTION- CHOTHIA et al., Nature, (19890000), vol. 342, pages 878 - 883
DESCRIPTION- CHOTHIA; LESK, J. Mol. Biol., (19870000), vol. 196, pages 901 - 917
DESCRIPTION- CLACKSON et al., Nature, (19910000), vol. 352, pages 624 - 628
DESCRIPTION- Current Protocols in Immunology, Wiley-Interscience, (19910000), vol. 1 and 2
DESCRIPTION- DAVID et al., Biochemistry, (19740000), vol. 13, page 1014
DESCRIPTION- DEMBO, A. et al., Ann. Prob., (19940000), vol. 22, pages 2022 - 2039
DESCRIPTION- "Evaluating the statistical significance of multiple distinct local alignments", ALTSCHUL, S.F., Theoretical and Computational Methods in Genome Research, Plenum, (19970000), pages 1 - 14
DESCRIPTION- GADIOT, J. et al., Cancer, (20110000), vol. 117, pages 2192 - 2201
DESCRIPTION- GAO et al., Clin Cancer Res, (20090000), vol. 15, pages 971 - 979
DESCRIPTION- GHEBEH et al., Neoplasia, (20060000), vol. 8, pages 190 - 198
DESCRIPTION- GISH, W. et al., Nature Genet, (19930000), vol. 3, pages 266 - 272
DESCRIPTION- HAMANISHI, J et al., PNAS, (20070000), vol. 104, pages 3360 - 3365
DESCRIPTION- HANCOCK, J.M. et al., Comput. Appl. Biosci., (19940000), vol. 10, pages 67 - 70
DESCRIPTION- HENIKOFF, S. et al., Proc. Natl. Acad. Sci. USA, (19920000), vol. 89, pages 10915 - 10919
DESCRIPTION- HUNTER et al., Nature, (19620000), vol. 144, page 945
DESCRIPTION- IWAI et al., PNAS, (20020000), vol. 99, pages 12293 - 12297
DESCRIPTION- KABAT, Adv. Prot. Chem., (19780000), vol. 32, pages 1 - 75
DESCRIPTION- KABAT et al., J. Biol. Chem., (19770000), vol. 252, pages 6609 - 6616
DESCRIPTION- KARLIN, S. et al., Proc. Natl. Acad. Sci. USA, (19900000), vol. 87, pages 2264 - 2268
DESCRIPTION- KARLIN, S. et al., Proc. Natl. Acad. Sci. USA, (19930000), vol. 90, pages 5873 - 5877
DESCRIPTION- KEIR, M.E. et al., Annu Rev Immunol., (20080000), vol. 26, pages 677 - 704
DESCRIPTION- KOHLER et al., Nature, (19750000), vol. 256, page 495
DESCRIPTION- LEONG et al., Appl. Immnunohistochem., (19960000), vol. 4, no. 3, page 201
DESCRIPTION- MADDEN, T.L. et al., Meth. Enzymol., (19960000), vol. 266, pages 131 - 141
DESCRIPTION- MARKS et al., J. Mol. Biol., (19910000), vol. 222, pages 581 - 597
DESCRIPTION- MCCARTY, K.S. JR et al., Cancer Res., (19860000), vol. 46, no. 8, pages 4244s - 4248s
DESCRIPTION- "Methods for the Preparation of Enzyme- Antibody Conjugates for use in Enzyme Immunoassay", O'SULLIVAN et al., Methods in Enzym, Academic press, (19810000), vol. 73, pages 147 - 166
DESCRIPTION- Natl. Biomed. Res. Found.
DESCRIPTION- NYGREN, J., Histochem. and Cytochem., (19820000), vol. 30, page 407
DESCRIPTION- OHIGASHI et al., Clin Cancer Res, (20050000), vol. 11, pages 2947 - 2953
DESCRIPTION- OKAZAKI T; HONJO T, Internat. immunol., (20070000), vol. 19, pages 813 - 824
DESCRIPTION- PAIN et al., J. Immunol. Meth., (19810000), vol. 40, page 219
DESCRIPTION- PRESTA, J. Allergy Clin. Immunol., (20050000), vol. 116, page 731
DESCRIPTION- SCHUURMAN, J, Mol. Immunol., (20010000), vol. 38, pages 1 - 8
DESCRIPTION- SCHWARTZ, R.M. et al., "Matrices for detecting distant relationships", Atlas of Protein Sequence and Structure, (19780000), vol. 5, pages 353 - 358
DESCRIPTION- SHARP A.H. et al., Nature Immunol., (20070000), vol. 8, pages 239 - 245
DESCRIPTION- STATES, D.J. et al., Methods, (19910000), vol. 3, pages 66 - 70
DESCRIPTION- TAUBE, J. M. et al., Sci Transl Med, (20120000), vol. 4, page 127ra37
DESCRIPTION- THOMPSON, R. H. et al., Cancer Res., (20060000), vol. 66, pages 3381 - 3385
DESCRIPTION- THOMPSON, R. H. et al., PNAS, (20040000), vol. 101, no. 49, pages 17174 - 17179
DESCRIPTION- TOPLIAN, S. L. et al., New Eng. J Med., (20120000), vol. 366, no. 26, pages 2443 - 2454
DESCRIPTION- WATSON et al., Molecular Biology of the Gene, The Benjamin/Cummings Pub. Co., (19870000), page 224
DESCRIPTION- W. A. WEBER, J. Nucl. Med., (20090000), vol. 50, pages 1S - 10S
DESCRIPTION- WOOTTON, J.C. et al., Comput. Chem., (19930000), vol. 17, pages 149 - 163
DESCRIPTION- YANG et al., Invest Ophthalmol Vis Sci., (20080000), vol. 49, no. 6, pages 2518 - 2525
DESCRIPTION- ZHANG, J. et al., Genome Res., (19970000), vol. 7, pages 649 - 656
DESCRIPTION- ROJA et al., "Review of imaging solutions for integrated, quantitative immunohistochemistry in the Pathology daily practice", Folia Histochemica et Cytobiologica, (20090000), vol. 47, no. 3, doi:doi:10.2478/v10042-008-0114-4, pages 349 - 354, XP055247918
INTERNATIONAL-SEARCH-REPORT- ABBOTT ET AL., "Binding to human dipeptidyl peptidase IV by adenosine deaminase and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted b propeller domain.", EUR. J. BIOCHEM., (19991201), vol. 266, pages 798 - 810, XP002261851
INTERNATIONAL-SEARCH-REPORT- SZNOL ET AL., "Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer.", CLIN CANCER RES., (20130301), vol. 19, pages 1021 - 1034, XP055123957
OPPOSITION- STROME et al., "B7-H1 blockade augments adoptive T-cell immunotherapy for squamous cell carcinoma", Cancer research, (20030000), vol. 63, no. 19, pages 6501 - 6505, XP002487684
OPPOSITION- MU, CHUAN-YONG et al., "High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation", Medical oncology, (20110000), vol. 28, no. 3, pages 682 - 688, XP019937695
OPPOSITION- DONG et al., "Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion", Nature medicine, (20020000), vol. 8, no. 8, pages 793 - 800, XP002397368
OPPOSITION- HUANG et al., "Clinical application of biological markers for treatments of resectable non-small-cell lung cancers", British journal of cancer, (20050000), vol. 92, no. 7, pages 1231 - 1239, XP055644012
OPPOSITION- TOPALIAN et al., "Safety, activity, and immune correlates of anti-PD-1 antibody in cancer", New England Journal of Medicine, (20120000), vol. 366, no. 26, pages 2443 - 2454, XP002767416
OPPOSITION- BRAHMER et al., "Safety and activity of anti-PD-L1 antibody in patients with advanced cancer", New England Journal of Medicine, (20120000), vol. 366, no. 26, pages 2455 - 2465, XP002685330
OPPOSITION- HAMANISHI et al., "Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer", PNAS, (20070000), vol. 104, no. 9, pages 3360 - 3365, XP055030513
OPPOSITION- ROSENBLATT et al., "PD-1 Blockade by CT-011, Anti-PD-1 Antibody, Enhances Ex Vivo T-cell Responses to Autologous Dendritic Cell/Myeloma Fusion Vaccine", NIH Public Access Author Manuscript,, (19970000), vol. 34, no. 5, pages 1 - 20, XP055493200
OPPOSITION- KIRKEGAARD et al., "Observer variation in immunohistochemical analysis of protein expression, time for a change?", Histopathology, (20060000), vol. 48, no. 7, pages 787 - 794, XP055644018
OPPOSITION- DETRE, S. et al., "A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas", Journal of clinical pathology, (19950000), vol. 48.9, pages 876 - 878, XP055301291
OPPOSITION- PATNAIK et al., "Phase I Study of MK-3475 (anti-PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors", Clinical cancer research, (20120000), vol. 21, no. 19, doi:10.1158/1078-0432.CCR-14-2607, pages 4286 - 4293, XP055370195
OPPOSITION- ZHANG et al., "PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model", Blood, (20090000), vol. 114, no. 8, pages 1545 - 1552, XP055053821
OPPOSITION- TOPALIAN, SUZANNE LOUISE et al., "Anti-PD-1 (BMS-936558, MDX-1106) in patients with advanced solid tumors: Clinical activity, safety, and a potential biomarker for response", ASCO annual meeting, (20120000), XP055301753
OPPOSITION- ZITVOGEL et al., "Targeting PD-1/PD-L1 interactions for cancer immunotherapy", Oncolmmunology, (20120000), vol. 1, no. 8, pages 1223 - 1225, XP002716013
SEARCH- CHUAN-YONG MU ET AL, "High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation", MEDICAL ONCOLOGY, SPRINGER-VERLAG, NEW YORK, (20100406), vol. 28, no. 3, doi:10.1007/S12032-010-9515-2, ISSN 1559-131X, pages 682 - 688, XP019937695 [X] 1-4,7,10,12,13,16,23,24 * Microscopic evaluation of tumor sections introduction subjects discussion;; figure 2 * [I] 1-25
SEARCH- J. HAMANISHI ET AL, "Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, (20070227), vol. 104, no. 9, doi:10.1073/pnas.0611533104, ISSN 0027-8424, pages 3360 - 3365, XP055030513
SEARCH- S DETRE ET AL, "A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas.", JOURNAL OF CLINICAL PATHOLOGY, GB, (19950901), vol. 48, no. 9, doi:10.1136/jcp.48.9.876, ISSN 0021-9746, pages 876 - 878, XP055301291
SEARCH- L. ZHANG ET AL, "PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model", BLOOD, (20090820), vol. 114, no. 8, doi:10.1182/blood-2009-03-206672, ISSN 0006-4971, pages 1545 - 1552, XP055053821
SEARCH- SUZANNE LOUISE TOPALIAN ET AL, "Anti-PD-1 (BMS-936558, MDX-1106) in patients with advanced solid tumors: Clinical activity, safety, and a potential biomarker for response.", 2012 ASCO ANNUAL MEETING, (20120621), XP055301753 [X] 18-22 * abstract *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents